The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
0604021 Informal Interpretation
0604019 Informal Interpretation
20060940: Mr. William J. McEnery; Isle of Capri Casinos, Inc.
20060927: Macquarie Infrastructure Company Trust; Loving Enterprises, Inc.
0604015 Informal Interpretation
0604018 Informal Interpretation
20060974: CHS Private Equity V LP; Allied Capital Corporation
20060957: President and Fellows of Harvard College; Sempra Energy
20060955: Pogo Producing Company; Warburg Pincus Private Equity VIII
0604017 Informal Interpretation
Allergan, Inc., and Inamed Corporation, In the Matter of
The consent order requires that Allergan and Inamed divest the rights to develop and distribute Reloxin, a potential Botox rival, to settle charges that Allergan’s $3.2 billion purchase of Inamed would reduce competition and force consumers to pay higher prices for botulinum toxin type A products. Under the terms of the FTC settlement, the companies will return the development and distribution rights to Reloxin to Ipsen Ltd., its U.K.- based manufacturer.